Clinical Trial Update: SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes [NA]

View source ↗

Summary

This clinical trial update covers SafeBoosC-IIIv, a study examining whether cerebral oximetry monitoring affects renal outcomes in neonates. The trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Neonatal Morbidity

Snippet

Sponsor: St. John's Research Institute | Conditions: Acute Renal Failure, Neonatal Morbidity | NA | Status: NOT_YET_RECRUITING